LENALIDOMID BMS caps 20 mg 21 pce
7680684900068
CH-68490
L04AX04
07.16.4.
Active substances:
1 / 3
google
Details
- Product number
- 6849006
- CPT
- -
- Packaging group
- 21
- Unit
- Kapsel(n)
- Composition
- lenalidomidum 20 mg, lactosum 244.5 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.8 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 132, E 172 (flavum), Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula.
Articles (1)
Lenalidomid BMS 20 mg, Hartkapseln
Kapseln
21
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
lenalidomidum
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
lactosum
|
244.5 MG | Substance | HBESI |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
natrium
|
0.8 MG | Substance | HBESI |
|
magnesii stearas
|
- | Substance | HNIDK |
|
gelatina
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 132
|
- | Substance | FIMDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
lacca
|
- | Substance | HNIDK |
|
propylenglycolum
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
E 172 (nigrum)
|
- | Substance | FTODK |
|
kalii hydroxidum
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 910.35
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/02/2022
Authorization holder
Bristol-Myers Squibb SA
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 68490
- Drug name
- Lenalidomid BMS, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L04AX04
- Authorization status
- Z
- Authorization category
- Category C
- Dispensation category
- A
- First authorization
- 14/06/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LENALIDOMID BMS caps 20 mg 21 pce
- Description (DE)
- LENALIDOMID BMS Kaps 20 mg 21 Stk
- Market launch
- 14/06/2021
- Narcotic (BTM)
- No